PC1-1

........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270.......280. MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF

PC1-2	........A............................................................................I.........................E......A.................................................................................................S..C.............................................................	97.86 %
PC1-3	........A..................................N...................................................................E................................................................................K..N......F...N..........................................................................	97.51 %
PC1-4	...............................................................................................................E................................................................................K..N......F...N..........................................................................	98.22 %
PC1-5	.........M.....................................................................................................E................................................................................K..N......F...N..........................................................................	97.86 %
PC1-6	............................................................................................................A..E......K...........N.......I.K...K...............................................K..N..........N........I.................................................................	96.09 %
PC1-7	...........................................N...................................................................E................................................................................K..N......F...N..........................................................................	97.86 %

Last updated: April 06, 2026.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database was funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu

Live statistics (since March 29th, 2025)